Literature DB >> 32627199

Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways.

Oliver S Eng1, Andrew M Blakely2, Kelly J Lafaro3, Keith F Fournier4, Nadege T Fackche3, Fabian M Johnston3, Sean Dineen5, Benjamin Powers5, Ryan Hendrix6, Laura A Lambert7, Sean Ronnekleiv-Kelly8, Kara Vande Walle8, Travis E Grotz9, Jennifer L Leiting9, Sameer H Patel10, Vikrom K Dhar10, Joel M Baumgartner11, Andrew M Lowy11, Callisia N Clarke12, Harveshp Mogal12, Mohammad Y Zaidi13, Charles A Staley13, Charles Kimbrough14, Jordan M Cloyd14, Byrne Lee15, Mustafa Raoof16.   

Abstract

BACKGROUND: Variations in care have been demonstrated both within and among institutions in many clinical settings. By standardizing perioperative practices, Enhanced Recovery After Surgery (ERAS) pathways reduce variation in perioperative care. We sought to characterize the variation in cytoreductive surgery (CRS)/heated intraperitoneal chemotherapy (HIPEC) perioperative practices among experienced US medical centers.
METHODS: Data from the US HIPEC Collaborative represents a retrospective multi-institutional cohort study of CRS and CRS/HIPEC procedures performed from 12 major academic institutions. Patient characteristics and perioperative practices were reported and compared. Institutional variation was analyzed using hierarchical mixed-effects linear (continuous outcomes) or logistic (binary outcomes) regression models.
RESULTS: A total of 2372 operations were included. CRS/HIPEC was performed most commonly for appendiceal histologies (64.2%). The rate of complications (overall 56.3%, range: 31.8-70.9) and readmissions (overall 20.6%, range: 8.9-33.3) varied by institution (P < .001). Institution-level variation in perioperative practice patterns existed among measured ERAS pathway process/outcomes (P < .001). The percentages of variation with each process/outcome measure attributable solely to institutional practices ranged from 0.6% to 66.6%.
CONCLUSIONS: Significant variation exists in the perioperative care of patients undergoing CRS/HIPEC at major US academic institutions. These findings provide a strong rationale for the investigation of best practices in CRS/HIPEC patients.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  ERAS; HIPEC; cytoreductive surgery; variation

Mesh:

Year:  2020        PMID: 32627199     DOI: 10.1002/jso.26099

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC.

Authors:  Ankit Dhiman; Emily Fenton; Jeffrey Whitridge; Jennifer Belanski; Whitney Petersen; Sarah Macaraeg; Govind Rangrass; Ardaman Shergill; Dejan Micic; Oliver S Eng; Kiran Turaga
Journal:  Ann Surg Oncol       Date:  2021-05-05       Impact factor: 5.344

2.  Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study.

Authors:  Kevin M Turner; Mackenzie C Morris; Aaron M Delman; Dennis Hanseman; Fabian M Johnston; Jonathan Greer; Kara Vande Walle; Daniel E Abbott; Mustafa Raoof; Travis E Grotz; Keith Fournier; Sean Dineen; Jula Veerapong; Ugwuji Maduekwe; Anai Kothari; Charles A Staley; Shishir K Maithel; Laura A Lambert; Alex C Kim; Jordan M Cloyd; Gregory C Wilson; Jeffrey J Sussman; Syed A Ahmad; Sameer H Patel
Journal:  J Gastrointest Surg       Date:  2022-10-18       Impact factor: 3.267

3.  Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery.

Authors:  Huiyu Deng; Zahra Eftekhari; Cameron Carlin; Jula Veerapong; Keith F Fournier; Fabian M Johnston; Sean P Dineen; Benjamin D Powers; Ryan Hendrix; Laura A Lambert; Daniel E Abbott; Kara Vande Walle; Travis E Grotz; Sameer H Patel; Callisia N Clarke; Charles A Staley; Sherif Abdel-Misih; Jordan M Cloyd; Byrne Lee; Yuman Fong; Mustafa Raoof
Journal:  JAMA Netw Open       Date:  2022-05-02

4.  Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey.

Authors:  Geetu Bhandoria; Sohan Lal Solanki; Mrugank Bhavsar; Kalpana Balakrishnan; Cherukuri Bapuji; Nitin Bhorkar; Prashant Bhandarkar; Sameer Bhosale; Jigeeshu V Divatia; Anik Ghosh; Vikas Mahajan; Abraham Peedicayil; Praveen Nath; Snita Sinukumar; Robin Thambudorai; Ramakrishnan Ayloor Seshadri; Aditi Bhatt
Journal:  Pleura Peritoneum       Date:  2021-06-21

5.  Implementation of the enhanced recovery after surgery protocol for patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion.

Authors:  Oleksandr Ivanovych Tkachenko; Sergii Hennadiiovych Chetverikov; Oleksandr Vadymovych Bondar; Viacheslav Yevheniiovych Maksymovskyi; Mykhailo Chetverikov; Valeriia Volodymyrivna Chetverikova-Ovchynnyk
Journal:  Contemp Oncol (Pozn)       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.